Identification of novel protective antigens from Anaplasma marginale

Vaccine

Volumn 21, Issue 17-18, 2003, Pages 1874-1883

  Riding, George ^a,b   Hope, Michelle ^a,b   Waltisbuhl, David ^c   Willadsen, Peter ^a,b  

^a Bancroft Centre   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c DEPARTMENT OF AGRICULTURE AND FISHERIES   (Australia)

Author keywords

Anaplasma marginale; Antigen; Vaccine

Indexed keywords

ANAPLASMOSIS VACCINE; IMMUNOGLOBULIN G ANTIBODY;

AMINO TERMINAL SEQUENCE; ANAPLASMA; ANAPLASMA MARGINALE; ARTICLE; ISOELECTRIC POINT; MOLECULAR WEIGHT; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0037449084     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00004-5     Document Type: Article

References (20)

1. Uilenberg G. International collaborative research: significance of tick-borne hemoparasitic diseases to world animal health. Vet. Parasitol. 57:1995;19-41.
2. Nari A. Strategies for the control of one-host ticks and relationship with tick-borne diseases in South America. Vet. Parasitol. 57:1995;153-165.
3. Callow L.L. Tick-borne livestock diseases and their vectors. 3. Australian methods of vaccination against anaplasmosis and babesiosis. World Anim. Rev. 18:1976;9-15.
4. Turton J.A., Katsande T.C., Matingo M.B., Jorgensen W.K., Ushewokunze-Obatolu U., Dalgleish R.J. Observations on the use of Anaplasma centrale for immunization of cattle against anaplasmosis in Zimbabwe. Onderstepoort J. Vet. Res. 65:1998;81-86.
5. Brizuela C.M., Ortellado C.A., Sanabria E., Torres O., Ortigosa D. The safety and efficacy of Australian tick-borne disease vaccine strains in cattle in Paraguay. Vet. Parasitol. 76:1998;27-41.
6. Bock R.E., de Vos A.J. Immunity following use of Australian tick fever vaccine: a review of the evidence. Aust. Vet. J. 79:2001;832-839.
7. Palmer GH, Lincoln S. Anaplasmosis. In: Smith BP, editor. Large animal internal medicine. 3rd ed. St. Louis: Mosby; 2001. p. 1049-51.
8. Palmer G.H., Rurangirwa F.R., Kocan K.M., Brown W.C. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol. Today. 15:1999;281-286.
9. French D.M., Brown W.C., Palmer G.H. Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia. Infect. Immun. 67:1999;5834-5840.
10. Barbet A.F., Lundgren A., Yi J., Rurangirwa F.R., Palmer G.H. Antigenic variation of Anaplasma marginale by expression of MSP-2 mosaics. Infect. Immun. 68:2000;6133-6138.
11. Brayton K.A., Knowles D.P., McGuire T.C., Palmer G.H. Efficient use of a small genome to generate antigenic diversity in tick-borne ehrlichial pathogens. Proc. Natl. Acad. Sci. U.S.A. 98:2001;4130-4135.
12. Meeus P.F.M., Barbet A.F. Ingenious gene generation. Trends Microbiol. 9:2001;353-355.
13. Barbet A.F., Yi J., Lundgren A., McEwen B.R., Blouin E.F., Kocan K.M. Antigenic variation of Anaplasma marginale: major surface protein 2 diversity during cyclic transmission between ticks and cattle. Infect. Immun. 69:2001;3057-3066.
14. Gale K.R., Leatch G., Dimmock C.M., Gartside M.G. Increased resistance to Anaplasma marginale infection in cattle chronically infected with Theileria buffeli. Vet. Parasitol. 69:1997;187-196.
15. Tebele N., McGuire T.C., Palmer G.H. Induction of protective immunity by using Anaplasma marginale initial body membranes. Infect. Immun. 59:1991;3199-3204.
16. Molloy M.P., Herbert B.R., Walsh B.J., Tyler M.I., Traini M., Sanchez J.-C.et al. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis. 19:1998;837-844.
17. Willadsen P., Riding G.A., McKenna R.V., Kemp D.H., Tellam R.L., Nielsen J.N.et al. Immunological control of a parasitic athropod-identification of a protective antigen from Boophilus microplus. J. Immunol. 143:1989;1346-1351.
18. Willadsen P, Riding G, Hope M. Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens. International Patent Application relating to immunity against rickettsieae and ehrlichieae. Application no. PCT/AU02/00468, filing date: 11 April 2002.
19. Montenegro-James S., James M.A., Toro Benitez M., Leon E., Baek B.K., Guillen A.T. Efficacy of purified Anaplasma marginale initial bodies as a vaccine against anaplasmosis. Parasitol. Res. 77:1991;93-101.
20. Brown W.C., Shkap V., Zhu D., McGuire T.C., Tuo W., McElwain T.F.et al. CD4+ T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect. Immun. 66:1998;5406-5413.